BioMaxima S.A. Logo

BioMaxima S.A.

Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.

BMX | WAR

Overview

Corporate Details

ISIN(s):
PLBIOMX00015
LEI:
2594007GAALFMXP4YB89
Country:
Poland
Address:
Lublin Vetterów 5, 20-277 Lublin
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMaxima S.A. is a manufacturer in the biotechnology sector specializing in the in vitro diagnostics (IVD) market. The company develops and produces a comprehensive range of solutions for laboratory diagnostics, supporting medical professionals and diagnosticians. Its portfolio encompasses microbiological media, reagents, specialized equipment, and IVD tests. Key application areas include clinical chemistry, haematology, and the diagnosis of infectious diseases, featuring systems for determining drug sensitivity and reference strains for microorganisms.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-27 12:45
Regulatory News Service
Informacja o otrzymaniu dofinansowania w kwocie 1.097.835,17 zł na rozbudowę of…
Polish 1.7 KB
2025-08-08 20:29
Director's Dealing
Zawiadomienie 19 MAR
Polish 8.0 KB
2025-08-08 20:29
Report Publication Announcement
Zawiadomienie od osoby zobowiązanej - Content (PL)
Polish 213 bytes
2025-07-15 12:07
Business and Financial Review
Podpisanie znaczącej umowy - Content (PL)
Polish 581 bytes
2025-06-27 14:00
Regulatory News Service
Podpisanie znaczącej umowy - Content (PL)
Polish 776 bytes
2025-06-25 13:05
Major Shareholding Notification
zal01_Wykaz_akcjonariuszy.pdf
Polish 127.8 KB
2025-06-25 13:05
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów podczas WZ w dniu 25.6.…
Polish 242 bytes
2025-06-25 13:03
Post-Annual General Meeting Information
Uchwały wraz z informacjami.
Polish 244.6 KB
2025-06-25 13:03
Post-Annual General Meeting Information
Uchwały podjęte podcza Walnego Zgromadzenia w dniu 25.6.2025 - Content (PL)
Polish 440 bytes
2025-06-05 12:18
Director's Dealing
zal01_powiadomienie_o_nabyciu_akcji_5_06_2025.pdf
Polish 6.0 KB
2025-06-05 12:18
Board/Management Information
Zawiadomienie od osoby zobowiązanej - Content (PL)
Polish 239 bytes
2025-05-30 17:01
Quarterly Report
Skonsolidowane sprawozdanie finansowe wraz z jednostkową informacją finansową
Polish 1.2 MB
2025-05-29 20:55
Remuneration Information
Sprawodanie o wynagrodzeniach
Polish 2.0 MB
2025-05-29 20:55
Business and Financial Review
Sprawozdanie Rady Nadzorczej
Polish 3.0 MB
2025-05-29 20:55
Pre-Annual General Meeting Information
Zawiadomienie o zwołaniu WZ wraz z projektami uchwał
Polish 315.6 KB

Automate Your Workflow. Get a real-time feed of all BioMaxima S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioMaxima S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG
Galderma Group AG Logo
A pure-play dermatology company with aesthetics, skincare, and therapeutic solutions.
Switzerland GALD

Talk to a Data Expert

Have a question? We'll get back to you promptly.